Physician profile
Veronica D Ramirez
NPI 1801199260
$82,859.14
in general payments reported to CMS, 2019-2025
9 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,575 · 2022: $7,309 · 2023: $11K · 2024: $24K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Travel and Lodging: $9,075 · Food and Beverage: $5,077 · Consulting Fee: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,412.50 |
| Travel and Lodging | $9,075.47 |
| Food and Beverage | $5,076.61 |
| Consulting Fee | $410.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $81,371.75 | 2021-2025 | Biktarvy, Descovy, Yeztugo |
| Viiv Healthcare Company | $980.53 | 2021-2025 | Apretude, Cabenuva, Dovato |
| Merck Sharp & Dohme LLC | $192.11 | 2021-2025 | Delstrigo, Pifeltro |
| Janssen Scientific Affairs, LLC | $114.80 | 2023 | Symtuza |
| Janssen Products, LP | $65.00 | 2022 | |
| Janssen Biotech, INC. | $42.33 | 2022 | |
| Emd Serono, INC. | $34.86 | 2021 | |
| Organon LLC | $29.28 | 2024 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.